Profil
Johannes Rolf Streffer worked as a Member-Alzheimer Disease Area at Janssen Pharmaceuticals, Inc. and as VP & Head-Translational Medicine Neuroscience at UCB Biopharma SRL.
He also served as Chief Medical Officer at AC Immune SA from 2021 to 2023.
Streffer completed his undergraduate degree at Eberhard Karls Universität Tübingen.
Anciens postes connus de Johannes Streffer
| Sociétés | Poste | Fin |
|---|---|---|
| AC IMMUNE SA | Directeur Technique/Scientifique/R&D | 30/09/2023 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | - |
UCB Biopharma SRL
UCB Biopharma SRL Medical DistributorsDistribution Services Wholesales pharmaceutical products and provides research & development on biotechnology | Corporate Officer/Principal | - |
Formation de Johannes Streffer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
AC Immune SA
AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Eberhard Karls Universität Tübingen
Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB Biopharma SRL
UCB Biopharma SRL Medical DistributorsDistribution Services Wholesales pharmaceutical products and provides research & development on biotechnology | Distribution Services |
















